South Korea’s Ministry of Agriculture, Food, and Rural Affairs and Hyundai Steel Co. have joined hands to use livestock excrements for producing solid fuel for making iron to reduce greenhouse gas emissions.
Last year, South Korea’s livestock excrement production reached 51.2 million tons as the number of livestock continued to increase.
Over 90 percent of this excrement is turned into manure or liquified fertilizer for farm use.
However, shrinking farmlands and heavier restrictions on compost spraying make excrement processing increasingly difficult.
Additionally, making and distributing compost generates ultrafine dust like ammonia and greenhouse gases, threatening the environment.
More than 21 million tons of compost made of cow excrement are being used annually, generating over 2,728,000 tCO2-eq of greenhouse gas.


NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
GesiaPlatform Launches Carbon-Neutral Lifestyle App ‘Net Zero Heroes’
SAP Beats Q2 Revenue Estimates as Cloud Backlog and Business AI Demand Drive Growth.
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
What’s so special about Ukraine’s minerals? A geologist explains
AMD Unveils Helios AI Servers to Challenge Nvidia as OpenAI Adopts New Platform
Japan Services Producer Prices Rise 3.2% in June, Supporting BOJ Rate Hike Expectations
How to create a thriving forest, not box-checking ‘tree cover’
Amkor Stock Surges 17% After $1.5 Billion Nvidia AI Packaging Partnership
We combed through old botanical surveys to track how plants on Australia’s islands are changing
Fertile land for growing vegetables is at risk — but a scientific discovery could turn the tide
Gold Price Holds Above $4,000 as Fed Rate Hike Bets Rise on Oil-Driven Inflation
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
India to Continue U.S. Trade Talks After Trump Imposes 10% Import Tariff
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



